Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma of Bone (Diagnosis)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00001873
What this trial is testing

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more
National Heart, Lung, and Blood Institute (NHLBI) 102
Large-scale testing (Phase 3)Active Not RecruitingNCT00572169
What this trial is testing

UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy

Who this might be right for
Multiple Myeloma
University of Arkansas 177
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Not applicableEnded earlyNCT02291965
What this trial is testing

Blood Samples to Identify Biomarkers of Busulfan

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Fred Hutchinson Cancer Center 139
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT00006220
What this trial is testing

Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Washington University School of Medicine 5
Not applicableStudy completedNCT00569842
What this trial is testing

Investigation of the Cylex® ImmuKnow® Assay

Who this might be right for
LeukemiaNon-Hodgkin's LymphomaChronic Lymphocytic Leukemia+6 more
Indiana University 45
Testing effectiveness (Phase 2)Study completedNCT00003960
What this trial is testing

Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Not applicableLooking for participantsNCT06988020
What this trial is testing

"Pseudo-scanner" MRI Sequences for the Detection of Bone Lesions in Multiple Myeloma

Who this might be right for
Multiple Myeloma Bone Disease
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 45
Large-scale testing (Phase 3)Ended earlyNCT00089141
What this trial is testing

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Cancer
Martin, Paul 151
Not applicableStudy completedNCT05260203
What this trial is testing

MargheRITA (Remote Intelligence for Therapeutic Adherence)

Who this might be right for
Multiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more
Advice Pharma Group srl 124
Testing effectiveness (Phase 2)Study completedNCT00002673
What this trial is testing

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 30
Early research (Phase 1)Study completedNCT01582295
What this trial is testing

XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease

Who this might be right for
Multiple Myeloma
Massachusetts General Hospital 4
Not applicableStudy completedNCT02921828
What this trial is testing

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Who this might be right for
Multiple Myeloma
Celgene 1,149
Early research (Phase 1)Study completedNCT00003107
What this trial is testing

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Indiana University
Early research (Phase 1)Study completedNCT00005092
What this trial is testing

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
M.D. Anderson Cancer Center 7
Very early researchLooking for participantsNCT06398457
What this trial is testing

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Who this might be right for
Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Not applicableEnded earlyNCT00594308
What this trial is testing

In-Vivo Activated T-Cell Depletion to Prevent GVHD

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more
Indiana University 10
Next Page